Non-pharmacological Treatment vs Pharmacological Treatment for Non-acute Lumbar Disc Herniation
Lumbar Disc Herniation
About this trial
This is an interventional treatment trial for Lumbar Disc Herniation
Eligibility Criteria
Inclusion Criteria: aged 19 to 69 years. lower back pain that has persisted for at least 1 month. a Numeric Rating Scale (NRS) score of 5 or higher for either lower back pain or radiating leg pain over the past three consecutive days. confirmed lumbar disc herniation on MRI that can explain the lower back pain. who have provided written informed consent and agreed to participate in the clinical study. Exclusion Criteria: diagnosed with specific severe diseases that could be the cause of lower back pain or leg pain (e.g., spinal metastasis, acute fractures, and spinal dislocation). showing progressive neurological deficits or severe neurological symptoms. with pain originating from soft tissue disorders other than the spine (e.g., tumors, fibromyalgia, rheumatoid arthritis, gout). with other chronic conditions (e.g., stroke and myocardial infarction, renal disease, diabetic neuropathy, dementia, epilepsy) that may interfere with the treatment effect or result interpretation. taking steroids, immunosuppressive drugs, psychiatric medications, or other medications that may impact the study results. acupuncture or nerve block treatment is inappropriate or unsafe, such as those with a history of bleeding disorders, receiving anticoagulant therapy, or diagnosed with uncontrolled diabetes. taken non-steroidal anti-inflammatory drugs (NSAIDs) or other pain-affecting drugs or received acupuncture treatment within the past 5 days. Pregnant women, those planning pregnancy, or breastfeeding women. within 3 months after lumbar surgery. who have not completed participation in another clinical study within the past month or have plans to participate in another clinical study within 6 months from the selection date or during the study participation and follow-up period. Inability to provide written informed consent. - Other cases where the researchers determine that participation in the clinical study would be difficult.
Sites / Locations
- Jaseng Hospital of Korean MedicineRecruiting
- Bucheon Jaseng Hospital of Korean MedicineRecruiting
- Haeundae Jaseng Hospital of Korean MedicineRecruiting
- Daejeon Jaseng Hospital of Korean MedicineRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Non-pharmacological treatment strategy
Pharmacological treatment strategy
Interventions: Non-pharmacological treatment include acupuncture, electroacupuncture, spinal manual therapy, and motion style acupuncture treatment. Frequency: Not specified (Twice a week recommended) Duration: Eight weeks.
Interventions: Active pharmacological treatment involving prescription medication, injection therapy, or other pharmacological interventions. Frequency: Not specified (Twice a week recommended) Duration: Eight weeks.